Figure 6
Changes on leukocyte and related classification after repeated administration of hUC-MSCs. Averaged WBC (A), Neut (B), Lymph (C), Mono (D), Eos (E), and Baso (F) count during the study are shown. (n = 10/group during dosing period; n = 4/group during recovery period). Data are presented as means ± SD. */#P < 0.05, **P < 0.01. #represents significant difference compared to Control group and High-dose group; *represents significant difference compared to Control group and Low-dose group.
